Go Pro
→ Ready to give options a try? Your first trade (Ticker included) -INSIDE (From Base Camp Trading) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AquaBounty Technologies, Inc. stock logo
AQB
AquaBounty Technologies
$1.15
-2.5%		$1.11
$0.77
▼
$2.95
$6.07M1.45897,275 shs50,922 shs
HCW Biologics Inc. stock logo
HCWB
HCW Biologics
$2.94
+2.4%		$3.43
$1.50
▼
$36.65
$5.27M2.37198,585 shs35,625 shs
Atrinsic Inc. stock logo
PTIX
Atrinsic
$1.06
+6.0%		$0.43
$0.13
▼
$4.55
$1.92M1.7730,788 shs1,682 shs
XTL Biopharmaceuticals Ltd. stock logo
XTLB
XTL Biopharmaceuticals
$2.46
-1.8%		$2.77
$2.01
▼
$10.28
$5.51M1.3812,090 shs1,829 shs
7 Stocks That Could Lead the Next Market Boom Cover
7 Stocks That Could Lead the Next Market Boom

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AquaBounty Technologies, Inc. stock logo
AQB
AquaBounty Technologies
-2.54%-8.00%+16.17%+17.35%-1.71%
HCW Biologics Inc. stock logo
HCWB
HCW Biologics
+2.44%-14.29%-14.29%-69.94%-89.79%
Atrinsic Inc. stock logo
PTIX
Atrinsic
+6.00%+8.15%+309.58%+112.00%-67.48%
XTL Biopharmaceuticals Ltd. stock logo
XTLB
XTL Biopharmaceuticals
-1.80%-0.61%-13.86%+19.17%-87.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AquaBounty Technologies, Inc. stock logo
AQB
AquaBounty Technologies
$1.15
-2.5%		$1.11
$0.77
▼
$2.95
$6.07M1.45897,275 shs50,922 shs
HCW Biologics Inc. stock logo
HCWB
HCW Biologics
$2.94
+2.4%		$3.43
$1.50
▼
$36.65
$5.27M2.37198,585 shs35,625 shs
Atrinsic Inc. stock logo
PTIX
Atrinsic
$1.06
+6.0%		$0.43
$0.13
▼
$4.55
$1.92M1.7730,788 shs1,682 shs
XTL Biopharmaceuticals Ltd. stock logo
XTLB
XTL Biopharmaceuticals
$2.46
-1.8%		$2.77
$2.01
▼
$10.28
$5.51M1.3812,090 shs1,829 shs
7 Stocks That Could Lead the Next Market Boom Cover
7 Stocks That Could Lead the Next Market Boom

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AquaBounty Technologies, Inc. stock logo
AQB
AquaBounty Technologies
-2.54%-8.00%+16.17%+17.35%-1.71%
HCW Biologics Inc. stock logo
HCWB
HCW Biologics
+2.44%-14.29%-14.29%-69.94%-89.79%
Atrinsic Inc. stock logo
PTIX
Atrinsic
+6.00%+8.15%+309.58%+112.00%-67.48%
XTL Biopharmaceuticals Ltd. stock logo
XTLB
XTL Biopharmaceuticals
-1.80%-0.61%-13.86%+19.17%-87.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AquaBounty Technologies, Inc. stock logo
AQB
AquaBounty Technologies
1.00
SellN/AN/A
HCW Biologics Inc. stock logo
HCWB
HCW Biologics
2.00
Hold$30.00920.41% Upside
Atrinsic Inc. stock logo
PTIX
Atrinsic
1.00
SellN/AN/A
XTL Biopharmaceuticals Ltd. stock logo
XTLB
XTL Biopharmaceuticals
1.00
SellN/AN/A

Current Analyst Ratings Breakdown

Latest PTIX, HCWB, AQB, and XTLB Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/28/2026
AquaBounty Technologies, Inc. stock logo
AQB
AquaBounty Technologies
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E+)
8/12/2026
AquaBounty Technologies, Inc. stock logo
AQB
AquaBounty Technologies
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
7/17/2026
HCW Biologics Inc. stock logo
HCWB
HCW Biologics
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
7/8/2026
AquaBounty Technologies, Inc. stock logo
AQB
AquaBounty Technologies
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
7/6/2026
XTL Biopharmaceuticals Ltd. stock logo
XTLB
XTL Biopharmaceuticals
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
(Data available from 9/5/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AquaBounty Technologies, Inc. stock logo
AQB
AquaBounty Technologies
N/AN/AN/AN/A$0.55 per shareN/A
HCW Biologics Inc. stock logo
HCWB
HCW Biologics
$50K108.19N/AN/A$4.05 per share0.73
Atrinsic Inc. stock logo
PTIX
Atrinsic
N/AN/AN/AN/A$1.96 per shareN/A
XTL Biopharmaceuticals Ltd. stock logo
XTLB
XTL Biopharmaceuticals
$450K12.00N/AN/A($0.12) per share-20.46
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AquaBounty Technologies, Inc. stock logo
AQB
AquaBounty Technologies
-$18.49M-$0.82N/AN/AN/AN/A-147.07%-28.73%11/10/2026 (Estimated)
HCW Biologics Inc. stock logo
HCWB
HCW Biologics
-$7.96M-$27.60N/AN/AN/A-83.03%-262.33%-34.90%11/12/2026 (Estimated)
Atrinsic Inc. stock logo
PTIX
Atrinsic
-$5.53M$2.23N/AN/AN/AN/AN/A-379.72%11/17/2026 (Estimated)
XTL Biopharmaceuticals Ltd. stock logo
XTLB
XTL Biopharmaceuticals
-$6.97M-$0.64N/AN/AN/AN/AN/AN/AN/A

Latest PTIX, HCWB, AQB, and XTLB Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2026Q2 2026
HCW Biologics Inc. stock logo
HCWB
HCW Biologics
-$1.98-$11.58-$9.60-$11.58$0.14 million$0.14 million
8/6/2026Q2 2026
AquaBounty Technologies, Inc. stock logo
AQB
AquaBounty Technologies
N/A-$0.26N/A-$0.32N/AN/A
6/30/2026Q4 2025
XTL Biopharmaceuticals Ltd. stock logo
XTLB
XTL Biopharmaceuticals
N/A-$0.10N/A-$0.10N/A($0.26) million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
AquaBounty Technologies, Inc. stock logo
AQB
AquaBounty Technologies
N/AN/AN/AN/AN/A
HCW Biologics Inc. stock logo
HCWB
HCW Biologics
N/AN/AN/AN/AN/A
Atrinsic Inc. stock logo
PTIX
Atrinsic
N/AN/AN/AN/AN/A
XTL Biopharmaceuticals Ltd. stock logo
XTLB
XTL Biopharmaceuticals
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AquaBounty Technologies, Inc. stock logo
AQB
AquaBounty Technologies
N/A
4.26
4.26
HCW Biologics Inc. stock logo
HCWB
HCW Biologics
N/A
0.06
0.06
Atrinsic Inc. stock logo
PTIX
Atrinsic
N/A
0.29
0.29
XTL Biopharmaceuticals Ltd. stock logo
XTLB
XTL Biopharmaceuticals
N/A
0.40
0.40

Institutional Ownership

CompanyInstitutional Ownership
AquaBounty Technologies, Inc. stock logo
AQB
AquaBounty Technologies
8.92%
HCW Biologics Inc. stock logo
HCWB
HCW Biologics
2.96%
Atrinsic Inc. stock logo
PTIX
Atrinsic
7.97%
XTL Biopharmaceuticals Ltd. stock logo
XTLB
XTL Biopharmaceuticals
4.40%

Insider Ownership

CompanyInsider Ownership
AquaBounty Technologies, Inc. stock logo
AQB
AquaBounty Technologies
1.02%
HCW Biologics Inc. stock logo
HCWB
HCW Biologics
9.10%
Atrinsic Inc. stock logo
PTIX
Atrinsic
8.00%
XTL Biopharmaceuticals Ltd. stock logo
XTLB
XTL Biopharmaceuticals
29.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
AquaBounty Technologies, Inc. stock logo
AQB
AquaBounty Technologies
1005.15 million5.10 millionNo Data
HCW Biologics Inc. stock logo
HCWB
HCW Biologics
401.84 million1.67 millionNot Optionable
Atrinsic Inc. stock logo
PTIX
Atrinsic
21.81 million1.78 millionNot Optionable
XTL Biopharmaceuticals Ltd. stock logo
XTLB
XTL Biopharmaceuticals
N/A2.20 million1.57 millionNot Optionable

Recent News About These Companies

XTL Biopharmaceuticals Ltd. Sponsored ADR
July 8, 2026  |  cnn.comhttps://www.cnn.com/markets/stocks/XTLB
XTL Biopharmaceuticals Ltd. American Depositary Shares (XTLB) After-Hours
July 1, 2026  |  nasdaq.comhttps://www.nasdaq.com/market-activity/stocks/xtlb/after-hours
XTL Biopharmaceuticals Completes Acquisition of Psyga Bio to Establish Psychedelic Biotechnology Platform
June 30, 2026  |  quiverquant.comQ
XTL Completed the Acquisition of Psyga Bio Ltd.
June 30, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/30/3320211/0/en/xtl-completed-the-acquisition-of-psyga-bio-ltd.html
XTL Biopharmaceuticals Adjourns Extraordinary Shareholder Meeting to June 29, 2026
June 23, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/xtl-biopharmaceuticals-adjourns-extraordinary-shareholder-meeting-to-june-29-2026?utm_source=marketbeat.com&utm_medium=referral
XTL Biopharmaceuticals Ltd.: XTL Announces Receipt of Staff Delist Determination from Nasdaq
May 23, 2026  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2026-05/68578824-xtl-biopharmaceuticals-ltd-xtl-announces-receipt-of-staff-delist-determination-from-nasdaq-399.htm
XTL Announces Receipt of Staff Delist Determination from Nasdaq
May 22, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/22/3300353/0/en/xtl-announces-receipt-of-staff-delist-determination-from-nasdaq.html
XTL Biopharmaceuticals Calls June 22, 2026 Meeting to Approve Psyga Bio Acquisition and Capital Raise
May 15, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/xtl-biopharmaceuticals-calls-june-22-2026-meeting-to-approve-psyga-bio-acquisition-and-capital-raise?utm_source=marketbeat.com&utm_medium=referral
XTL Biopharmaceuticals Ltd ADR XTLB
May 14, 2026  |  morningstar.comM
XTL Biopharmaceuticals Delays 20-F Amid Subsidiary Liquidation
May 3, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/XTLB/pressreleases/1657776/xtl-biopharmaceuticals-delays-20-f-amid-subsidiary-liquidation/
XTL Biopharmaceuticals Ltd.
May 1, 2026  |  marketwatch.comhttps://www.marketwatch.com/investing/stock/xtlb/financials?countrycode=il
Washington Just Opened the Door to Psychedelic Medicine; This Microcap Already Has a Key
May 1, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/commodities/JEZ25/pressreleases/1598440/washington-just-opened-the-door-to-psychedelic-medicine-this-microcap-already-has-a-key/
XTLB stock surges 50%, breaches 200-DMA for first time in over 3 months – here’s what the acquisition of Psyga Bio brings to the table
May 1, 2026  |  msn.comhttps://www.msn.com/en-us/money/other/xtlb-stock-surges-50-breaches-200-dma-for-first-time-in-over-3-months-here-s-what-the-acquisition-of-psyga-bio-brings-to-the-table/ar-AA2210wc
XTL Biopharmaceuticals to Acquire Psyga Bio, Establishing a Leading Psychedelic Biotechnology Platform with Advanced Clinical Pipeline, Licensed GMP Manufacturing and ...
April 29, 2026  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/xtl-biopharmaceuticals-to-acquire-psyga-bio-establishing-a-leading-psychedelic-biotechnology-platform-with-advanced-clinical-pipeline-licensed-gmp-manufacturing-and-proprietary-psilocybin-1036078577
XTL Biopharmaceuticals (XTLB) acquisition of Psyga Bio targets psychedelic biotech growth
April 29, 2026  |  msn.comhttps://www.msn.com/en-us/money/other/xtl-biopharmaceuticals-xtlb-acquisition-of-psyga-bio-targets-psychedelic-biotech-growth/ar-AA220P8R
XTL Biopharmaceuticals soars after all-stock Psyga Bio acquisition announcement
April 29, 2026  |  quiverquant.comQ
XTL Biopharmaceuticals to Acquire PsygaBio in All-Stock Deal to Expand Psychedelic Drug Pipeline
April 29, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/xtl-biopharmaceuticals-to-acquire-psygabio-in-all-stock-deal-to-expand-psychedelic-drug-pipeline?utm_source=marketbeat.com&utm_medium=referral
XTL Biopharmaceuticals to Acquire Psyga Bio, Establishing a Leading Psychedelic Biotechnology Platform with Advanced Clinical Pipeline, Licensed GMP Manufacturing and Proprietary Psilocybin Technologies
April 29, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/04/29/3283784/0/en/xtl-biopharmaceuticals-to-acquire-psyga-bio-establishing-a-leading-psychedelic-biotechnology-platform-with-advanced-clinical-pipeline-licensed-gmp-manufacturing-and-proprietary-psi.html
XTL Biopharmaceuticals Ltd.: XTL Biopharmaceuticals Announces ADS Ratio Change
March 21, 2026  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2026-03/68002842-xtl-biopharmaceuticals-ltd-xtl-biopharmaceuticals-announces-ads-ratio-change-399.htm
XTL Biopharmaceuticals Announces ADS Ratio Change
March 20, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/03/20/3259945/0/en/xtl-biopharmaceuticals-announces-ads-ratio-change.html

New MarketBeat Followers Over Time

Media Sentiment Over Time

AquaBounty Technologies stock logo

AquaBounty Technologies NASDAQ:AQB

$1.15 -0.03 (-2.54%)
As of 09/4/2026 04:00 PM Eastern

AquaBounty Technologies, Inc., a biotechnology company, operates in the aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It also operates salmon farms using proprietary technology. In addition, the company offers AquAdvantage Salmon, a genetically engineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts. The company was formerly known as Aqua Bounty Farms, Inc. and changed its name to AquaBounty Technologies, Inc. in June 2004. AquaBounty Technologies, Inc. was incorporated in 1991 and is headquartered in Harvard, Massachusetts.

HCW Biologics stock logo

HCW Biologics NASDAQ:HCWB

$2.94 +0.07 (+2.44%)
As of 09/4/2026 04:00 PM Eastern

HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases in the United States. The company's lead products include HCW9218, which is in Phase 1 clinical chemo-refractory/chemo-resistant solid tumors with pancreatic, ovarian, breast, prostate, and colorectal cancers, as well as Phase 2 clinical trial with metastatic advanced stage ovarian cancer patients; and HCW9302 for autoimmune and proinflammatory diseases, such as alopecia areata diseases. It also develops HCW9201, a cell-based therapy that is in Phase I clinical trials for the treatment of patients with relapsed/refractory acute myelogenous leukemia; and HCW9206, an injectable immunotherapeutic to use as adjuvant for adoptive cell therapy in cancer treatment. HCW Biologics Inc. was incorporated in 2018 and is headquartered in Miramar, Florida.

Atrinsic stock logo

Atrinsic NASDAQ:PTIX

$1.06 +0.06 (+6.00%)
As of 09/4/2026 12:22 PM Eastern

Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound comprises PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. Protagenic Therapeutics, Inc. is headquartered in New York, New York.

XTL Biopharmaceuticals stock logo

XTL Biopharmaceuticals NASDAQ:XTLB

$2.46 -0.05 (-1.80%)
As of 09/4/2026 03:57 PM Eastern
This is a fair market value price provided by Massive. Learn more.

XTL Biopharmaceuticals Ltd. engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases. Its pipeline includes hCDR1 and Erythropoietin. The company was founded on March 9, 1993 and is headquartered in Ramat Gan, Israel.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas